FDA recall, , Low risk
New York Blood Center Apheresis Red Blood Cells
Apheresis Red Blood Cells, Leukocytes Reduced, Irradiated were possibly manufactured with an incorrect ratio of blood to anticoagulant.
Recall ended Aug 31, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
New York Blood Center Enterprises recalled Apheresis Red Blood Cells, Leukocytes Reduced, Irradiated on March 25, 2026, because the blood cells were possibly manufactured with an incorrect ratio of blood to anticoagulant. The recall was added to the FDA's Enforcement Report and classified on August 31, 2026, and involves distribution in New York.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Red Blood Cells, Leukocytes Reduced, Irradiated
Recall details
- Company began the recall
- Sold in
- Company
- New York Blood Center Enterprises
- Hazard
- Blood donor screening
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 99428
- Recall number
- B-0221-2026
All recalls from New York Blood Center Enterprises
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
